The obstructive sleep apnoea/hypopnoea syndrome - An overview

Athanasia Pataka; Renata L. Riha

doi:10.1016/j.rmedc.2009.03.001

The obstructive sleep apnoea/hypopnoea syndrome - An overview

Athanasia Pataka, Renata L. Riha^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract / Description of output

In the last 30 years, there has been an explosion in facilities for the diagnosis and treatment of the obstructive sleep apnoea/hypopnoea syndrome (OSAHS) as well as a rapid advancement in the understanding of its consequences. In the general population, the prevalence of OSAHS is approximately 3-7% in adult men and 2-5% in adult women. OSAHS has been recognised as an independent risk factor for disorders such as hypertension, cardiovascular disease and sleepiness-related accidents. Currently, it is considered to be a systemic disease. This review provides a general overview of OSAHS: its epidemiology, pathophysiology, clinical features, diagnosis and treatment, as well as its consequences for public health. Crown

Original language	English
Pages (from-to)	111-117
Number of pages	7
Journal	Respiratory Medicine
Volume	2
Issue number	3
DOIs	https://doi.org/10.1016/j.rmedc.2009.03.001
Publication status	Published - 29 Apr 2009

Keywords / Materials (for Non-textual outputs)

Consequences
Diagnosis
Obstructive sleep apnoea/hypopnoea syndrome
Review
Risk factors
Treatment

Access to Document

10.1016/j.rmedc.2009.03.001

Cite this

@article{b7129fdf2e6940a1a14a2d12b1ce7fec,

title = "The obstructive sleep apnoea/hypopnoea syndrome - An overview",

abstract = "In the last 30 years, there has been an explosion in facilities for the diagnosis and treatment of the obstructive sleep apnoea/hypopnoea syndrome (OSAHS) as well as a rapid advancement in the understanding of its consequences. In the general population, the prevalence of OSAHS is approximately 3-7% in adult men and 2-5% in adult women. OSAHS has been recognised as an independent risk factor for disorders such as hypertension, cardiovascular disease and sleepiness-related accidents. Currently, it is considered to be a systemic disease. This review provides a general overview of OSAHS: its epidemiology, pathophysiology, clinical features, diagnosis and treatment, as well as its consequences for public health. Crown",

keywords = "Consequences, Diagnosis, Obstructive sleep apnoea/hypopnoea syndrome, Review, Risk factors, Treatment",

author = "Athanasia Pataka and Riha, {Renata L.}",

year = "2009",

month = apr,

day = "29",

doi = "10.1016/j.rmedc.2009.03.001",

language = "English",

volume = "2",

pages = "111--117",

journal = "Respiratory Medicine",

issn = "0954-6111",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - The obstructive sleep apnoea/hypopnoea syndrome - An overview

AU - Pataka, Athanasia

AU - Riha, Renata L.

PY - 2009/4/29

Y1 - 2009/4/29

N2 - In the last 30 years, there has been an explosion in facilities for the diagnosis and treatment of the obstructive sleep apnoea/hypopnoea syndrome (OSAHS) as well as a rapid advancement in the understanding of its consequences. In the general population, the prevalence of OSAHS is approximately 3-7% in adult men and 2-5% in adult women. OSAHS has been recognised as an independent risk factor for disorders such as hypertension, cardiovascular disease and sleepiness-related accidents. Currently, it is considered to be a systemic disease. This review provides a general overview of OSAHS: its epidemiology, pathophysiology, clinical features, diagnosis and treatment, as well as its consequences for public health. Crown

AB - In the last 30 years, there has been an explosion in facilities for the diagnosis and treatment of the obstructive sleep apnoea/hypopnoea syndrome (OSAHS) as well as a rapid advancement in the understanding of its consequences. In the general population, the prevalence of OSAHS is approximately 3-7% in adult men and 2-5% in adult women. OSAHS has been recognised as an independent risk factor for disorders such as hypertension, cardiovascular disease and sleepiness-related accidents. Currently, it is considered to be a systemic disease. This review provides a general overview of OSAHS: its epidemiology, pathophysiology, clinical features, diagnosis and treatment, as well as its consequences for public health. Crown

KW - Consequences

KW - Diagnosis

KW - Obstructive sleep apnoea/hypopnoea syndrome

KW - Review

KW - Risk factors

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=67349174222&partnerID=8YFLogxK

U2 - 10.1016/j.rmedc.2009.03.001

DO - 10.1016/j.rmedc.2009.03.001

M3 - Article

AN - SCOPUS:67349174222

SN - 0954-6111

VL - 2

SP - 111

EP - 117

JO - Respiratory Medicine

JF - Respiratory Medicine

IS - 3

ER -

The obstructive sleep apnoea/hypopnoea syndrome - An overview

Abstract / Description of output

Keywords / Materials (for Non-textual outputs)

Access to Document

Other files and links

Fingerprint

Cite this